Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If you need an accessible version of this item please contact JSTOR User Support

Coadministration of Oral Levofloxacin With Agents That Impair Absorption: Impact on Antibiotic Resistance

Keira A. Cohen , BS, Ebbing Lautenbach , MD, MPD, MSCE, Mark G. Weiner , MD, Marie Synnestvedt , MSED and Leanne B. Gasink , MD, MSCE
Infection Control and Hospital Epidemiology
Vol. 29, No. 10 (October 2008), pp. 975-977
DOI: 10.1086/590666
Stable URL: http://www.jstor.org/stable/10.1086/590666
Page Count: 3
  • Subscribe ($19.50)
  • Cite this Item
Item Type
Article
References
If you need an accessible version of this item please contact JSTOR User Support
Coadministration of Oral Levofloxacin With Agents That Impair Absorption: Impact on Antibiotic Resistance
Preview not available

Abstract

Coadministration of oral divalent or trivalent cation‐containing compounds with oral fluoroquinolones may impair fluoroquinolone absorption. Among 3,134 patients who received a course of oral levofloxacin, coadministration was significantly associated with subsequent identification of a levofloxacin‐resistant isolate. Strategies to curb the emergence of fluoroquinolone resistance should include avoiding the coadministration of divalent or trivalent cation‐containing compounds and fluoroquinolone.

Page Thumbnails